chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report was received from a patient on 05 December 2011. A 78-year-old female patient had received and intramuscular (IM) injection of FLUZONE HIGH-DOSE (lot number not reported) in left deltoid "one month ago" 2011. On an unspecified date, the patient developed fever, chills and an upset stomach after the vaccine. No further informational was available at the time of the report. The patient outcome was reported as not recovered/not resolved. Follow-up information was received from a consumer on 26 January 2012, who is also the patient. She reported that her symptoms appeared four hours after the vaccine. She was ill for three days and could not go to work after receiving the vaccination. The patient never had any effects from previous vaccinations; always got the normal dose. The patient husband took the normal dose with no adverse effects. The patient  outcome was reported as recovered/resolved "three days later". Documents held by sender: none.
Child threw up about 7 times in about 2 hours. A few hours later in the morning she had diarrhea which has continued most of the day into the afternoon.  She now has a mild fever.
Angioedema of the face and throat starting on 1/5/22, presented to the ER placed on prednisone  20mg (3 doses) and benadryl 25 mg (3 doses).  Allergy consultation on 1/11/22, presumable PEG allergy, stopped Qelbree and anything with PEG in it.  Continued with intermittent generalized urticarial rashes.  Allergy testing for PEG negative on 1/25/22, presumable vaccine  with persistent symptoms
This spontaneous report as received from a pharmacist as part of a market research, refers to a 71 year old female patient with no relevant medical history. In June 2009, the patient was vaccinated with a dose of ZOSTAVAX (dose, route, lot number and expiration date were not reported). There was not concomitant therapy. In June 2011, two years after vaccination, the patient developed a mild case of shingles (coded as herpes zoster). The patient recovered in less than 1 week (on an unknown date in 2011). The reporter considered herpes zoster to be not related to ZOSTAVAX. Additional information has been requested.
4:47am  March 27th Wednesday morning, patient has a temperature of 102.4. I, and pt's mom, woke her up, gave a cool wash down, 2.5ml Tylenol (as stated by the doctor if she ever has a temperature after shots) and a cooler than room temperature bottle. She went back to sleep. I stayed up (2 hours later) just to watch her. Around 6:40am-6:50am I took her again (you're supposed to check their temperature every two hours when temperatures is high) and it was 100.2. I finally went to sleep feeling assured that her temperature was going down. My mom called me around 8am and I hopped up and looked over and my baby was blue in the face and not breathing.
approx 1wk p/vax pt had a gen rash; sl fever which inc to 102;fever lasted 3 days & was relieved p/started on ATb;rash lasted approx 1wk;
caught the flu of another strain of flu; was so sick; Initial information was received on 11-Nov-2020 regarding an unsolicited valid non-serious case received from a consumer (patient) via social media.   This case involves a patient (unknown demographics) who got sick (illness) and caught the flu of another strain(influenza), after the patient received INFLUENZA VACCINE (flu shot).  The patient's medical history, past medical treatment(s), concomitant therapy, past vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, (Unknown latency) the patient caught the flu (illness) and was so sick (illness) from the INFLUENZA VACCINE (non serious events). The patient reported that flu was of another strain and patient did not got one since then.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the outcome was unknown for the reported event.  There will be no information available on batch number for this case.
After 12 hours, high fever above 103, tremors After 24 hours, dizziness and nausea, body aches  After  48 hours, vertigo, fainted and hit head on the floor After I fainted I felt totally back to normal
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable consumer. The reporter reported the same events for three patients. This is the third of the report.   A 90-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: E10140, expiration date: 31Mar2021) via unspecified route single dose for COVID-19 immunization, first dose on 23Dec2020, second dose on 13Jan2021, at 90-year-old. Medical history included: chronic kidney disease; anemia; a fib; heart disease. Concomitant medication was not reported. The facility discovered that the patient at the facility tested positive for COVID after receiving both doses of the vaccine. Lab data included: positive COVID-19 PCR test on 23Mar2021. Outcome of the event was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021376654 same reporter, product and adverse event, different patients;US-PFIZER INC-2021376693 same reporter, product and adverse event, different patients
This case was reported by a consumer and described the occurrence of diarrhea in a 9-year-old male subject who was vaccinated with HAVRIX (GlaxoSmithKline) for prophylaxis. A physician or other health care professional has not verified this report. The subject's medical history included seasonal allergy. Concurrent medical conditions included asthma. Concurrent medications included ADVAIR. On 23 August 2007 in the morning and 18 October 2007 the subject received 1st dose and 2nd dose of HAVRIX (unknown). At an unspecified time after vaccination with HAVRIX, the subject experienced diarrhea, fever, headache, sore throat and inappropriate schedule of vaccine administered. Medical attention was required in the emergency room and a healthcare professional was consulted. At the time of reporting, the diarrhea, fever, headaches and sore throat were unresolved.
Patient received vaccine at pharmacy with no side effect/reaction even after 30 minutes post administration.  Mild skin reaction (approx 1.5 inches x 1 in) ocurred 36 hours later and presents as warm, red rash, slightly sore and itchy, but does not seem to be worsening.  Patient reported also being nauseated the day following the vaccine administration but now is fine.  Patient has not treated, but was advised to use diphenhydramine orally if needed.  Patient was also advised to call MD if reaction worsens or other symptoms present.
Pt vaccinated with DTP and developed fever to 104 for several hrs inconsolable cry, swollen red arm x 1day.
Moderate-severe pain in arm at injection site with redness of large surrounding area still there 5 days later.  Mild rash all over my body still present 5 days later. Sensitive skin and flushing still 5 days later. Headache still 5 days later. Severe fatigue for 2 days after.
I get sharp pains in my chest that do not feel like other pains I?ve had before. It is different from heartburn or acid reflux. I happens at random times. It usually lasts for a few minutes, sometimes longer, and then goes away.
migraine headache; This case was reported by a other health professional via call center representative and described the occurrence of migraine headache in a 56-year-old female patient who received Herpes zoster (Shingrix) (batch number F9YH3, expiry date 7th December 2021) for prophylaxis.   On 31st October 2019, the patient received the 1st dose of Shingrix (intramuscular). On 1st November 2019, 1 days after receiving Shingrix, the patient experienced migraine headache. On an unknown date, the outcome of the migraine headache was unknown.   It was unknown if the reporter considered the migraine headache to be related to Shingrix.  Additional information was received as follows: One day later after receiving first dose of Shingrix, the patient experienced migraine headache.
Immune Response to the Vaccine. Toe was infected the following day for a week and a half.  To return to normal right after 10 days. The left Shoulder hurt and spread throughout the body. Then she experiences Fibromyalgia for 5 days after the Vaccine was administered  (21-26MAR21).
The patient is a 96-year-old gentleman who presented with complaints of cough and shortness of breath.  Patient was felt to be suffering from viral pneumonia secondary to COVID 19.  Patient was placed in the hospital and put on supplementary oxygen to maintain appropriate saturations.  He was started on Decadron and remdesivir during his hospitalization.  With treatment and time the patient was able to be weaned from oxygen while maintaining appropriate saturations on room air.  On day of discharge the patient was feeling relatively well and was comfortable being discharged home.  Questions have been answered to the patient's satisfaction and he is being discharged in improved and stable condition.
Patient started with a sore, red lump a few days after the injection. 3 months later, continues to have an ill-defined lump underneath the site of injection in the right arm
I started feeling worst anymore and woke up and my arm was sore; little sore onthe injection site; I started feeling worst anymore and woke up and my arm was sore; Rigorous, just shaking uncontrollably; Fever; profuse sweating; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 60-years-old female (non pregnant) patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot Number: en6201), dose 1 via an unspecified route of administration on 20Feb2021 13:30 (at the age of 60-years-old) as SINGLE DOSE for covid-19 immunization. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There was other medications the patient received within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 to vaccination. Medical history included drug hypersensitivity, seasonal allergy, blood pressure increased, vascular device user from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported.  The patient had the Covid vaccine on Saturday afternoon and didn't feel anything. She was really impress the way it went. Sunday, on an unspecified date, she started feeling worst anymore and woke up and her arm was sore. It was not that big deal. Then by Sunday night on 21Feb2021 , she started to have a severe not chills but rigorous she meant just rigorous, just shaking uncontrollably and then her fever went up. This was same thing Monday and sweat so bad so profusely (on 21Feb2021). But it was such a violent reaction, she was wondering was that normal. She was enquiring that she should get second dose or what. She meant it was, she better today. She felt like she had been drunk to (statement incomplete). She had not none of today but that was terrible. She asked was that normal. Since the vaccination, the patient had not been tested for COVID-19. The patient did not received treatment for the adverse event  rigorous, just shaking uncontrollably, fever and profuse sweating. The outcome of event i started feeling worst anymore and woke up and my arm was sore, little sore on the injection site was unknown. The outcome of rest event was not recovered.  No follow-up attempts are needed. No further information is expected
Pt called the pharmacy complaining of high fever, pain that radiated to the spine, headache, etc on 10.14.18 and was referred to the emergency room. The emergency room admitted her to the hospital for leukocytosis of unknown origin, possibly related to the vaccination.
MODERNA 0.5 cc giveN. SyRiNgE CHECKED FOR CORRECT DOSE, AIR BUBBLES, + TigHT CONNECTION. DURINg INJECTION SLigHT AMOUNT VACCINE LEAKED OUT ON TO ARM.
Received the vaccine at 330p.  Began to have mild upper eyelid itching around 11:59p.   Eyes felt swollen then began to feel nauseous (tried to vomit, but no food came up) and then a runny nose  (clear fluid).   I took another Claritin 10mg and also Zofran 8mg ODT which resolved the nausea.  Had to blow my nose 2 times.   Went to sleep with my Epipen at bedside but didnt have to use it.   Woke up at 815am and only symptom remaining was arm soreness.   Felt like my normal self and played 3 hrs of tennis.  Arm soreness at injection site worsened during the day.  By 72 hrs post-injection, arm soreness resolved.
It was a 2nd shingles vaccination. My side effects were in line with the warning of possible side effects. I had all of them. Mild fever (101.5F) for 48hrs. night sweats and shaking for 2 nights. Headache for 48 hours. Muscle ache/tenderness at point of injection plus neck muscle ache, back ache, lethargy for 2 days.
My son received GARDASIL shot to prevent HVP. approximately one week before he started 7th grade. He threw up within 3 days of receiving the medicine. He did not stop throwing up for a week. He almost missed his first day of 7th grade. I reported the problem to the doctor. Also, he was on competitive travel mens gymnastics team. Since receiving the shot he stopped having energy and became weak and tired all the time. He has since quit gymnastics. Entering 7th grade he had only missed 3 days of school his whole life. In 7th grade after getting that shoe he missed over 7 that year. And went to school feeling ill a few times so he would not miss any more school. He now gets car sick which never happened before and he loses energy. It has changed his life. I blame the shot.
On both shots, one month apart I experienced Covid arm. Swelling, itchiness and gland swollen in arm pit.  On shot 2 received this week, I experienced fatigue, chills and severe-migraine-like headache the day after.  Symptoms began April 6th at 2:30 am and persisted all day. Lessened headache on Wednesday but experienced fever like sweat at 4:00 am. Thursday morning at 12:30 am awakened fully drenched with sweat-hair dripping and clothing  needed changed. Headache gone.
Thrombocytopenia (CMS/HCC) Prostate cancer (CMS/HCC) Pain VOMITING DEATH
Initial reaction: rash on chest; muscle, joint pain; muscle, joint pain; urge to run; inability to sleep; Irritable mood; Muscle spasms; dry eyes; Dry mouth; brain fog, inability to multitask; This is a spontaneous report from a contactable nurse. A 58-years-old non-pregnant female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), Lot number: EJ1685; intramuscular in left arm on 18Dec2020 at 14:45 (at the age of 58 years-old) as a single dose for COVID-19 immunization.  The vaccine was given in a hospital. The patient did not receive any other vaccines in the past 4 weeks. Medical history included asthma, mitral valve prolapse and an allergy to latex. Concomitant medication included calcium (CALCIUM), metoprolol (METOPROLOL), magnesium (MG [MAGNESIUM]), ergocalciferol (VIT D).  The patient previously took penicillin and experienced an allergy. The patient did not receive any other vaccines in the past 4 weeks. She did take other medications (concomitant) in the past 2 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. In Dec2020, at 14:45, the patient experienced rash on chest followed by muscle, joint pain, urge to run, inability to sleep, irritable mood, muscle spasms, dry eyes, dry mouth, brain fog, and an inability to multitask after 1 week following COVID-19 vaccine. The patient was not hospitalized for the events and no treatment was administered. The outcome of the events: rash on chest followed by muscle, joint pain, urge to run, inability to sleep, irritable mood, muscle spasms, dry eyes, dry mouth. brain fog, inability to multitask, was recovering. Since the vaccination, the patient had not been tested for COVID-19.
Large red plaque on arm; Not able to lift arm; Severe pain shooting from ear and neck to pinky finger; Arm a rash, 6 inch circle; Fever; Lethargy; Pain localized to arm; Severe Diarrhea; Nausea; This spontaneous case was reported by a physician and describes the occurrence of LETHARGY (Lethargy), DIARRHOEA (Severe Diarrhea), PAIN (Pain localized to arm), ERYTHEMA (Large red plaque on arm) and INJECTED LIMB MOBILITY DECREASED (Not able to lift arm) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Jan-2021, the patient experienced LETHARGY (Lethargy), PAIN (Pain localized to arm) and PYREXIA (Fever). In January 2021, the patient experienced DIARRHOEA (Severe Diarrhea) and NAUSEA (Nausea). On 23-Jan-2021, the patient experienced ERYTHEMA (Large red plaque on arm), INJECTED LIMB MOBILITY DECREASED (Not able to lift arm), PAIN IN EXTREMITY (Severe pain shooting from ear and neck to pinky finger) and RASH (Arm a rash, 6 inch circle). The patient was treated with IBUPROFEN at an unspecified dose and frequency. In January 2021, LETHARGY (Lethargy), PAIN (Pain localized to arm), ERYTHEMA (Large red plaque on arm), PAIN IN EXTREMITY (Severe pain shooting from ear and neck to pinky finger) and PYREXIA (Fever) had resolved. At the time of the report, DIARRHOEA (Severe Diarrhea), INJECTED LIMB MOBILITY DECREASED (Not able to lift arm), RASH (Arm a rash, 6 inch circle) and NAUSEA (Nausea) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product information was not provided.  Treatment information includes ice and heat.   Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: No specific follow-up information recorded.
Hot Flashes and headache, patient reports that she feels weird and not herself.  No spike in actual temperature reported.
started my period early; messed with my hormones; PMS symptoms; emotionally all over the place; felt generally unwell; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 02Aug2021 08:00 (Lot number: FA7485) at the age of 39 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "consistently long cycle. The only time it was ever short" (unspecified if ongoing), notes: this was when on the pill over 15 years ago. The patient's concomitant medications were not reported. The following information was reported: MALAISE (non-serious) with onset 02Aug2021 10:00, outcome "recovered" (03Aug2021), described as "felt generally unwell"; MENSTRUAL DISORDER (non-serious) with onset 06Aug2021, outcome "recovered" (Aug2021), described as "started my period early"; HORMONE LEVEL ABNORMAL (non-serious) with onset 02Aug2021 10:00, outcome "recovered" (03Aug2021), described as "messed with my hormones"; PREMENSTRUAL SYNDROME (non-serious) with onset 02Aug2021 10:00, outcome "recovered" (03Aug2021), described as "PMS symptoms"; EMOTIONAL DISORDER (non-serious) with onset 02Aug2021 10:00, outcome "recovered" (03Aug2021), described as "emotionally all over the place". Therapeutic measures were not taken as a result of malaise, menstrual disorder, hormone level abnormal, premenstrual syndrome, emotional disorder.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, no covid  prior vaccination and not tested for covid post vaccination. No known drug allergy. No follow-up attempts are possible. No further information is expected.
Itching on left arm at site of vaccine immediately after the vaccine was given. The next day, Jan. 13, I had pain in the left arm. On Jan. 16, I started to get aches and pains all over my body, and my skin felt hot all over -- flu-like symptoms, but I did not have a fever.  The vaccine was Zostavax, the vaccine that is supposed to prevent shingles, and I received the vaccine at the clinic at my place of employment. On Jan. 19, I saw my own personal physician because the symptoms persisted.  He prescribed Motrin for the pain and Benadryl for the itch, to relieve the symptoms. The symptoms still have not gone away as of this date. They are intermittent, however, sometimes they go away for a few hours, but later return.
Starting having strange pain on my side and upper back then on 10/16/2016, broke out with a rash that was diagnosed as Shingles.  Started on medication.
chest congestion; sinus drainage; heavy feeling in my chest; I have coughing; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Nov-2021 and was forwarded to Moderna on 08-Nov-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY CONGESTION (chest congestion) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039F21A, 002A21A and 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Immunosuppressant drug therapy. Concomitant products included DICLOFENAC DIETHYLAMINE (VOLTAREN [DICLOFENAC DIETHYLAMINE]), ATORVASTATIN CALCIUM (LIPITOR), OMEPRAZOLE, LOSARTAN, HYDROXYCHLOROQUINE, METFORMIN HYDROCHLORIDE (METFORMIN ER), PREDNISONE, HYDROCHLOROTHIAZIDE and LINAGLIPTIN (TRADJENTA) for an unknown indication.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PULMONARY CONGESTION (chest congestion) (seriousness criterion medically significant), SINUS OPERATION (sinus drainage), CHEST DISCOMFORT (heavy feeling in my chest) and COUGH (I have coughing). At the time of the report, PULMONARY CONGESTION (chest congestion), SINUS OPERATION (sinus drainage), CHEST DISCOMFORT (heavy feeling in my chest) and COUGH (I have coughing) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   treatment to the events not reported.; Sender's Comments: Case is non serious
Fever 103.5, body aches, chills, nausea, vomiting
09/29/2005 temperature, rash 10/03/2005. 10/04/2005 seen in office T 105, rash worse, decrease in food intake, decrease urinary output- IV fluid.
24 hours after receiving the flu vaccine, the patient developed nausea and vertigo. He has had lingering symptoms of tinnitus since that time.
EMPLOYEE RECEIVED A HEP B VACCINE YESTERDAY AND BEGAN FEELING LIGHT HEADED, DIZZINESS AND A HEADACHE APPROXIMATELY AN HOUR AFTER RECEIVING VACCINATION. STAFF REPORTS FEELING AS IF SHE IS "GOING TO PASS OUT". STAFF CONTINUED TO HAVE SYMPTOMS THE NEXT DAY AFTER RECEIVING THE VACCINE. STAFF ADVISED TO SELF CARE BY ON CALL WORKPLACE INJURY NURSE.